TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
SMP00320	Intracellular Signalling Through Adenosine Receptor A2a and Adenosine	4.44796710004934e-05	-10.0204783046209	38	9	0.183673469387755	49	995	2778,5599,55970,5906,9693,8874,10411,1386,5605	GNAS,MAPK8,GNG12,RAP1A,RAPGEF2,ARHGEF7,RAPGEF3,ATF2,MAP2K2
SMP00321	Intracellular Signalling Through Adenosine Receptor A2b and Adenosine	4.44796710004934e-05	-10.0204783046209	38	9	0.183673469387755	49	995	2778,5599,55970,5906,9693,8874,10411,1386,5605	GNAS,MAPK8,GNG12,RAP1A,RAPGEF2,ARHGEF7,RAPGEF3,ATF2,MAP2K2
SMP00390	Tay-Sachs Disease	0.000683915980337016	-7.28767548365125	16	5	0.102040816326531	49	995	3098,64841,10007,10020,5238	HK1,GNPNAT1,GNPDA1,GNE,PGM3
SMP00045	Amino Sugar Metabolism	0.000683915980337016	-7.28767548365125	16	5	0.102040816326531	49	995	3098,64841,10007,10020,5238	HK1,GNPNAT1,GNPDA1,GNE,PGM3
SMP00240	Salla Disease/Infantile Sialic Acid Storage Disease	0.000683915980337016	-7.28767548365125	16	5	0.102040816326531	49	995	3098,64841,10007,10020,5238	HK1,GNPNAT1,GNPDA1,GNE,PGM3
SMP00534	G(M2)-Gangliosidosis: Variant B- Tay-sachs disease	0.000683915980337016	-7.28767548365125	16	5	0.102040816326531	49	995	3098,64841,10007,10020,5238	HK1,GNPNAT1,GNPDA1,GNE,PGM3
SMP00216	Sialuria or French Type Sialuria	0.000683915980337016	-7.28767548365125	16	5	0.102040816326531	49	995	3098,64841,10007,10020,5238	HK1,GNPNAT1,GNPDA1,GNE,PGM3
SMP00217	Sjogren Larsson Syndrome	0.000683915980337016	-7.28767548365125	16	5	0.102040816326531	49	995	3098,64841,10007,10020,5238	HK1,GNPNAT1,GNPDA1,GNE,PGM3
SMP00420	Bevacizumab Pathway	0.00690914681488134	-4.97490911989935	3	2	0.0408163265306122	49	995	7422,2321	VEGFA,FLT1
SMP00582	Joubert syndrome	0.0167239801294344	-4.09091165363523	21	4	0.0816326530612245	49	995	200576,23236,5295,8821	PIKFYVE,PLCB1,PIK3R1,INPP4B
SMP00463	Phosphatidylinositol Phosphate Metabolism	0.0167239801294344	-4.09091165363523	21	4	0.0816326530612245	49	995	200576,23236,5295,8821	PIKFYVE,PLCB1,PIK3R1,INPP4B
SMP00322	Vasopressin Regulation of Water Homeostasis	0.0313982319434659	-3.46100369518619	6	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00343	Intracellular Signalling Through PGD2 receptor and Prostaglandin D2	0.0313982319434659	-3.46100369518619	6	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00308	Dopamine Activation of Neurological Reward System	0.0313982319434659	-3.46100369518619	6	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00310	Corticotropin Activation of Cortisol Production	0.0425892752424925	-3.15615281227346	7	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00123	Betaine Metabolism	0.0425892752424925	-3.15615281227346	7	2	0.0408163265306122	49	995	191,4548	AHCY,MTR
SMP00335	Intracellular Signalling Through Histamine H2 Receptor and Histamine	0.0550243970729997	-2.89997860895814	8	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00354	Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin	0.0550243970729997	-2.89997860895814	8	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00309	Excitatory Neural Signalling Through 5-HTR 4 and Serotonin	0.0550243970729997	-2.89997860895814	8	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00311	Excitatory Neural Signalling Through 5-HTR 7 and  Serotonin 	0.0550243970729997	-2.89997860895814	8	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00340	Methylenetetrahydrofolate Reductase Deficiency (MTHFRD)	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00214	S-Adenosylhomocysteine (SAH) Hydrolase Deficiency	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00221	Methionine Adenosyltransferase Deficiency	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00177	Cystathionine Beta-Synthase Deficiency	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00341	Hypermethioninemia	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00033	Methionine Metabolism	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00222	Glycine N-methyltransferase Deficiency	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00570	Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism- cblG complementation type	0.0623720225379954	-2.7746384609116	19	3	0.0612244897959184	49	995	191,4548,4507	AHCY,MTR,MTAP
SMP00312	Excitatory Neural Signalling Through 5-HTR 6 and Serotonin 	0.0685592235551586	-2.68005732979819	9	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00333	Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone	0.0830600879823069	-2.48819098151803	10	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00338	Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin	0.0830600879823069	-2.48819098151803	10	2	0.0408163265306122	49	995	2778,55970	GNAS,GNG12
SMP00358	Fc Epsilon Receptor I Signaling in Mast Cells	0.137723393958477	-1.98250799691134	41	4	0.0816326530612245	49	995	5599,1432,5605,5295	MAPK8,MAPK14,MAP2K2,PIK3R1
SMP00124	Glycerol Phosphate Shuttle	0.14071698862793	-1.96100457852648	3	1	0.0204081632653061	49	995	2820	GPD2
SMP00522	3-hydroxyisobutyric aciduria	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00524	Isovaleric acidemia	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00523	Isobutyryl-coa dehydrogenase deficiency	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00237	3-Methylcrotonyl Coa Carboxylase Deficiency Type I	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00238	Isovaleric Aciduria	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00199	Maple Syrup Urine Disease	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00521	3-hydroxyisobutyric acid dehydrogenase deficiency	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00236	Propionic Acidemia	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00200	Methylmalonic Aciduria	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00384	Methylmalonate Semialdehyde Dehydrogenase Deficiency	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00140	3-Methylglutaconic Aciduria Type III	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00139	3-Methylglutaconic Aciduria Type I	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00032	Valine- Leucine and Isoleucine Degradation	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00173	Beta-Ketothiolase Deficiency	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00141	3-Methylglutaconic Aciduria Type IV	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00137	2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00138	3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency	0.179858047938543	-1.71558736178193	30	3	0.0612244897959184	49	995	34,1629,3712	ACADM,DBT,IVD
SMP00450	Phytanic Acid Peroxisomal Oxidation	0.183161411569375	-1.69738748446723	4	1	0.0204081632653061	49	995	224	ALDH3A2
SMP00433	Irinotecan Pathway	0.183161411569375	-1.69738748446723	4	1	0.0204081632653061	49	995	7150	TOP1
SMP00600	Irinotecan Pathway	0.183161411569375	-1.69738748446723	4	1	0.0204081632653061	49	995	7150	TOP1
SMP00451	Refsum Disease	0.183161411569375	-1.69738748446723	4	1	0.0204081632653061	49	995	224	ALDH3A2
SMP00561	Fructosuria	0.220840263220752	-1.51031562965996	18	2	0.0408163265306122	49	995	3098,6652	HK1,SORD
SMP00064	Fructose and Mannose Degradation	0.220840263220752	-1.51031562965996	18	2	0.0408163265306122	49	995	3098,6652	HK1,SORD
SMP00468	Degradation of Superoxides	0.22354999969569	-1.49812017766341	5	1	0.0204081632653061	49	995	847	CAT
SMP00021	Taurine and Hypotaurine Metabolism	0.22354999969569	-1.49812017766341	5	1	0.0204081632653061	49	995	84890	ADO
SMP00479	Plasmalogen Synthesis	0.22354999969569	-1.49812017766341	5	1	0.0204081632653061	49	995	8540	AGPS
SMP00063	Tryptophan Metabolism	0.239483585653864	-1.42927040037187	19	2	0.0408163265306122	49	995	847,10352	CAT,WARS2
SMP00650	Doxorubicin Pathway	0.295736049922801	-1.21828794571354	22	2	0.0408163265306122	49	995	847,873	CAT,CBR1
SMP00449	Ethanol Degradation	0.298545532914062	-1.2088328187068	7	1	0.0204081632653061	49	995	847	CAT
SMP00525	Fabry disease	0.314434330269256	-1.15698003141983	23	2	0.0408163265306122	49	995	55331,259230	ACER3,SGMS1
SMP00526	Krabbe disease	0.314434330269256	-1.15698003141983	23	2	0.0408163265306122	49	995	55331,259230	ACER3,SGMS1
SMP00349	Gaucher Disease	0.314434330269256	-1.15698003141983	23	2	0.0408163265306122	49	995	55331,259230	ACER3,SGMS1
SMP00034	Sphingolipid Metabolism	0.314434330269256	-1.15698003141983	23	2	0.0408163265306122	49	995	55331,259230	ACER3,SGMS1
SMP00347	Metachromatic Leukodystrophy (MLD)	0.314434330269256	-1.15698003141983	23	2	0.0408163265306122	49	995	55331,259230	ACER3,SGMS1
SMP00348	Globoid Cell Leukodystrophy	0.314434330269256	-1.15698003141983	23	2	0.0408163265306122	49	995	55331,259230	ACER3,SGMS1
SMP00487	Hyperphenylalaniemia due to guanosine triphosphate cyclohydrolase deficiency	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00496	Galactosemia III	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	80146	UXS1
SMP00005	Pterine Biosynthesis	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00488	Hyperphenylalaninemia due to 6-pyruvoyltetrahydropterin synthase deficiency (ptps)	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00495	Galactosemia II (GALK)	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	80146	UXS1
SMP00010	Nucleotide Sugars Metabolism	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	80146	UXS1
SMP00481	Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	34	ACADM
SMP00490	Segawa syndrome	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00491	Sepiapterin reductase deficiency	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00486	Dopa-responsive dystonia	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00489	Hyperphenylalaninemia due to dhpr-deficiency	0.333334266606056	-1.09860948885386	8	1	0.0204081632653061	49	995	873	CBR1
SMP00136	2-Hydroxyglutric Aciduria (D And L Form)	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	7915	ALDH5A1
SMP00567	Succinic semialdehyde dehydrogenase deficiency	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	7915	ALDH5A1
SMP00339	Hyperinsulinism-Hyperammonemia Syndrome	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	7915	ALDH5A1
SMP00243	4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	7915	ALDH5A1
SMP00452	Threonine and 2-Oxobutanoate Degradation	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	1629	DBT
SMP00385	Homocarnosinosis	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	7915	ALDH5A1
SMP00072	Glutamate Metabolism	0.366431146988128	-1.00394464163978	9	1	0.0204081632653061	49	995	7915	ALDH5A1
SMP00025	Phospholipid Biosynthesis	0.387937330160997	-0.946911472608273	27	2	0.0408163265306122	49	995	5130,2820	PCYT1A,GPD2
SMP00029	Selenoamino Acid Metabolism	0.427868166211696	-0.848940153718997	11	1	0.0204081632653061	49	995	191	AHCY
SMP00187	Glycerol Kinase Deficiency	0.456358470943612	-0.784476657808246	12	1	0.0204081632653061	49	995	2820	GPD2
SMP00530	Familial lipoprotein lipase deficiency	0.456358470943612	-0.784476657808246	12	1	0.0204081632653061	49	995	2820	GPD2
SMP00529	D-glyceric acidura	0.456358470943612	-0.784476657808246	12	1	0.0204081632653061	49	995	2820	GPD2
SMP00039	Glycerolipid Metabolism	0.456358470943612	-0.784476657808246	12	1	0.0204081632653061	49	995	2820	GPD2
SMP00185	Glutaric Aciduria Type I	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00345	Congenital Erythropoietic Porphyria (CEP) or Gunther Disease	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	1355	COX15
SMP00540	Very-long-chain acyl coa dehydrogenase deficiency (VLCAD)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00545	Trifunctional protein deficiency	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00344	Acute Intermittent Porphyria	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	1355	COX15
SMP00542	Medium chain acyl-coa dehydrogenase deficiency (MCAD)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00198	Malonic Aciduria	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00024	Porphyrin Metabolism	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	1355	COX15
SMP00201	Methylmalonic Aciduria Due to Cobalamin-Related Disorders	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00235	Short Chain Acyl CoA Dehydrogenase Deficiency (SCAD Deficiency)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00342	Hereditary Coproporphyria (HCP)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	1355	COX15
SMP00181	Ethylmalonic Encephalopathy	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00043	Galactose Metabolism	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	3098	HK1
SMP00462	Inositol Phosphate Metabolism	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	8821	INPP4B
SMP00346	Porphyria Variegata (PV)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	1355	COX15
SMP00538	Carnitine palmitoyl transferase deficiency (I)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00541	Carnitine palmitoyl transferase deficiency (II)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00182	Galactosemia	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	3098	HK1
SMP00502	Malonyl-coa decarboxylase deficiency	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00051	Fatty acid Metabolism	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00016	Propanoate Metabolism	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00539	Long chain acyl-CoA dehydrogenase deficiency (LCAD)	0.509232110303102	-0.674851353990358	14	1	0.0204081632653061	49	995	34	ACADM
SMP00040	Glycolysis	0.533745491134783	-0.627836161997637	15	1	0.0204081632653061	49	995	5223	PGAM1
SMP00531	Glycogenosis- Type VII. Tarui disease	0.533745491134783	-0.627836161997637	15	1	0.0204081632653061	49	995	5223	PGAM1
SMP00572	Fanconi-bickel syndrome	0.533745491134783	-0.627836161997637	15	1	0.0204081632653061	49	995	5223	PGAM1
SMP00306	Pindolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00323	Quinidine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00379	Nifedipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00325	Disopyramide Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00380	Nimodipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00381	Nisoldipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00324	Procainamide (Antiarrhythmic) Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00366	Nebivolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00377	Felodipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00296	Acebutolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00305	Penbutolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00327	Phenytoin (Antiarrhythmic) Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00588	Muscle/Heart Contraction	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00298	Atenolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00304	Oxprenolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00332	Ibutilide Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00378	Isradipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00303	Nadolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00297	Alprenolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00331	Flecainide Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00359	Diltiazem Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00375	Verapamil Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00382	Nitrendipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00329	Mexiletine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00302	Metoprolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00300	Bisoprolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00376	Amlodipine Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00299	Betaxolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00330	Tocainide Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00307	Propranolol Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00326	Fosphenytoin (Antiarrhythmic) Pathway	0.554774818714486	-0.589192979613191	58	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00555	Glycogenosis- Type VI. Hers disease	0.557058216578736	-0.585085526421809	16	1	0.0204081632653061	49	995	178	AGL
SMP00058	Starch and Sucrose Metabolism	0.557058216578736	-0.585085526421809	16	1	0.0204081632653061	49	995	178	AGL
SMP00557	Sucrase-isomaltase deficiency	0.557058216578736	-0.585085526421809	16	1	0.0204081632653061	49	995	178	AGL
SMP00556	Mucopolysaccharidosis VI. Sly syndrome	0.557058216578736	-0.585085526421809	16	1	0.0204081632653061	49	995	178	AGL
SMP00552	Glycogen synthetase deficiency	0.557058216578736	-0.585085526421809	16	1	0.0204081632653061	49	995	178	AGL
SMP00368	Labetalol Pathway	0.566819810497315	-0.567713820299134	59	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00367	Carvedilol Pathway	0.566819810497315	-0.567713820299134	59	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00328	Lidocaine (Antiarrhythmic) Pathway	0.578674708505402	-0.547014775339761	60	3	0.0612244897959184	49	995	7168,488,23236	TPM1,ATP2A2,PLCB1
SMP00011	Inositol Metabolism	0.579227927905273	-0.546059221004588	17	1	0.0204081632653061	49	995	200576	PIKFYVE
SMP00649	Lamivudine Pathway	0.600309555240049	-0.510309831409659	18	1	0.0204081632653061	49	995	5130	PCYT1A
SMP00355	Mitochondrial Electron Transport Chain	0.65753715059178	-0.419254013725254	21	1	0.0204081632653061	49	995	2820	GPD2
SMP00128	Gluconeogenesis	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00092	Rosuvastatin Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00508	Cholesteryl ester storage disease	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00510	Mevalonic aciduria	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00581	Glycogenosis- Type IA. Von gierke disease	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00387	CHILD Syndrome	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00095	Alendronate pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00107	Zoledronate Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00389	Smith-Lemli-Opitz Syndrome (SLOS)	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00574	Glycogenosis- Type IC	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00112	Risedronate Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00119	Fluvastatin Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00079	Ibandronate Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00563	Triosephosphate isomerase	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00209	Hypercholesterolemia	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00562	Fructose-1-6-diphosphatase deficiency	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00388	Chondrodysplasia Punctata II- X Linked Dominant (CDPX2)	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00386	Desmosterolosis	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00511	Wolman disease	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00023	Steroid Biosynthesis	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00099	Lovastatin Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00509	Hyper-IgD syndrome	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00131	Atorvastatin Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00082	Simvastatin Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00117	Pamidronate Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00374	Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00560	Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1)	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00319	Lysosomal Acid Lipase Deficiency (Wolman Disease)	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00573	Glycogenosis- Type IB	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	5223	PGAM1
SMP00089	Pravastatin Pathway	0.674765774433056	-0.393389649168247	22	1	0.0204081632653061	49	995	6646	SOAT1
SMP00102	Bromfenac Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00098	Ketorolac Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00106	Meloxicam Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00085	Ketoprofen Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00353	Leukotriene C4 Synthesis Deficiency	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00094	Sulindac Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00114	Nabumetone Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00109	Mefanamic Acid Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00113	Oxaprozin Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00289	Diflunisal Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00077	Piroxicam Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00083	Acetylsalicylic Acid Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00084	Etodolac Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00075	Arachidonic Acid Metabolism	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00093	Diclofenac Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00101	Suprofen Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00087	Rofecoxib Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00116	Valdecoxib Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00120	Naproxen Pathway	0.761661281344039	-0.2722533347924	28	1	0.0204081632653061	49	995	873	CBR1
SMP00411	Hydrocodone Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00104	Indomethacin Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	873	CBR1
SMP00417	Sufentanil Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00404	Ropivacaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00425	Escitalopram Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00392	Benzocaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00410	Hydromorphone Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00399	Mepivacaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00416	Remifentanil Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00393	Bupivacaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00396	Dibucaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00415	Fentanyl Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00401	Prilocaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00400	Oxybuprocaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00394	Chloroprocaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00414	Carfentanil Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00397	Levobupivacaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00413	Alfentanil Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00395	Cocaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00412	Oxymorphone Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00403	Proparacaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00402	Procaine Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00409	Oxycodone Pathway	0.77373842427523	-0.256521415644216	29	1	0.0204081632653061	49	995	3751	KCND2
SMP00423	Desipramine Pathway	0.78521546072697	-0.241797126596694	30	1	0.0204081632653061	49	995	3751	KCND2
SMP00398	Lidocaine (Local Anaesthetic) Pathway	0.796121618679893	-0.228003317522245	31	1	0.0204081632653061	49	995	3751	KCND2
SMP00405	Codeine Pathway	0.806484731425331	-0.21507031349276	32	1	0.0204081632653061	49	995	3751	KCND2
SMP00429	Disulfiram Pathway	0.806484731425331	-0.21507031349276	32	1	0.0204081632653061	49	995	847	CAT
SMP00407	Heroin Pathway	0.806484731425331	-0.21507031349276	32	1	0.0204081632653061	49	995	3751	KCND2
SMP00422	Imipramine Pathway	0.816331302725333	-0.202934998175245	33	1	0.0204081632653061	49	995	3751	KCND2
SMP00096	Celecoxib Pathway	0.825686569010759	-0.191540033876397	34	1	0.0204081632653061	49	995	873	CBR1
SMP00426	Fluoxetine Pathway	0.825686569010759	-0.191540033876397	34	1	0.0204081632653061	49	995	3751	KCND2
SMP00424	Citalopram Pathway	0.834574558729363	-0.180833194479622	35	1	0.0204081632653061	49	995	3751	KCND2
SMP00408	Methadone Pathway	0.834574558729363	-0.180833194479622	35	1	0.0204081632653061	49	995	3751	KCND2
SMP00336	Vitamin A Deficiency	0.843018148962716	-0.170766792193385	36	1	0.0204081632653061	49	995	9249	DHRS3
SMP00074	Retinol Metabolism	0.843018148962716	-0.170766792193385	36	1	0.0204081632653061	49	995	9249	DHRS3
SMP00431	Nicotine Pathway	0.843018148962716	-0.170766792193385	36	1	0.0204081632653061	49	995	3751	KCND2
SMP00406	Morphine Pathway	0.89697437143387	-0.108727988754176	44	1	0.0204081632653061	49	995	3751	KCND2
SMP00086	Ibuprofen Pathway	0.91210811553697	-0.0919967481961281	47	1	0.0204081632653061	49	995	873	CBR1
SMP00455	Homocysteine Degradation	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00265	Abciximab Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00612	Esomeprazole Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00616	Rabeprazole Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00267	Tirofiban Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00613	Omeprazole Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00515	Homocystinuria- cystathionine beta-synthase deficiency	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00464	Vitamin K Metabolism	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00614	Lansoprazole Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00615	Pantoprazole Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00514	Gamma-cystathionase deficiency (CTH)	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00266	Eptifibatide Pathway	0.999999999999541	-4.58721602369927e-13	2	0	0	49	995
SMP00631	Prednisone Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00476	Trastuzumab Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00593	Enalapril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00473	Gefitinib Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00632	Prednisolone Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00268	Warfarin Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00261	Ticlopidine Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00595	Moexipril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00475	Panitumumab Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00647	Thioguanine Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00474	Cetuximab Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00591	Benazepril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00597	Ramipril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00596	Quinapril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00617	Cimetidine Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00391	Insulin Signalling	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00421	Vatalanib Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00592	Cilazapril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00036	D-Arginine and D-Ornithine Metabolism	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00149	Fosinopril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00611	Ticlopidine Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00470	Fluorouracil Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00599	Trandolapril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00263	Cilostazol Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00594	Fosinopril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00598	Spirapril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00156	Spirapril Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00301	Esmolol Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00264	Dipyridamole (Antiplatelet) Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00440	Prednisone Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00638	Levomethadyl Acetate Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00441	Prednisolone Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00472	Erlotinib Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00608	Fluorouracil Pathway	1.00000000000006	6.432354648922e-14	1	0	0	49	995
SMP00653	Rosiglitazone Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00602	Teniposide Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00126	Phenylacetate Metabolism	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00619	Felodipine Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00564	Multiple carboxylase deficiency- neonatal or early onset form	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00635	Valproic Acid Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00443	Teniposide Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00626	Desipramine Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00645	Azathioprine Pathway	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00459	Pyruvaldehyde Degradation	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00456	Fatty Acid Biosynthesis	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00174	Biotinidase Deficiency	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00066	Biotin Metabolism	1.00000000000104	1.04502318528255e-12	3	0	0	49	995
SMP00418	Adefovir Dipivoxil Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00153	Quinapril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00623	Heroin Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00165	Valsartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00618	Fosphenytoin (Antiarrhythmic) Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00150	Lisinopril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00633	Felbamate Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00164	Telmisartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00076	Thiamine Metabolism	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00419	Tenofovir Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00651	Artemether Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00170	Aromatic L-Aminoacid Decarboxylase Deficiency	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00145	Benazepril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00620	Lidocaine (Local Anaesthetic) Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00621	Codeine Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00152	Perindopril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00469	Capecitabine Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00012	Catecholamine Biosynthesis	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00607	Capecitabine Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00065	Ubiquinone Biosynthesis	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00163	Olmesartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00629	Adefovir Dipivoxil Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00154	Ramipril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00497	Tyrosine hydroxylase deficiency	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00148	Enalapril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00162	Losartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00155	Rescinnamine Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00161	Irbesartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00639	Clomipramine Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00146	Captopril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00160	Forasartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00129	Malate-Aspartate Shuttle	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00587	Angiotensin metabolism	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00159	Eprosartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00147	Cilazapril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00630	Tenofovir Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00151	Moexipril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00158	Candesartan Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00157	Trandolapril Pathway	1.00000000000127	1.26623375921607e-12	4	0	0	49	995
SMP00055	Alanine Metabolism	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00070	Riboflavin Metabolism	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00352	Primary Hyperoxaluria Type I	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00350	Pyruvate Carboxylase Deficiency	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00641	Doxepin Pathway	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00313	Lactic Acidemia	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00018	Alpha Linolenic Acid and Linoleic Acid Metabolism	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00503	Hypophosphatasia	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00637	Tramadol Pathway	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00017	Vitamin B6 Metabolism	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00569	Succinyl CoA: 3-ketoacid CoA transferase deficiency	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00071	Ketone Body Metabolism	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00465	Carnitine Synthesis	1.0000000000013	1.29809383338032e-12	5	0	0	49	995
SMP00054	Fatty Acid Elongation In Mitochondria	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00634	Carbamazepine Pathway	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00627	Citalopram Pathway	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00480	Mitochondrial Beta-Oxidation of Short Chain Saturated Fatty Acids	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00544	Long-chain-3-hydroxyacyl-coa dehydrogenase deficiency (LCHAD)	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00568	Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency (SCHAD)	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00041	Sulfate/Sulfite Metabolism	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00532	Sulfite oxidase deficiency	1.00000000000131	1.31076358839536e-12	7	0	0	49	995
SMP00646	Fluoxetine Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00445	Spermidine and Spermine Biosynthesis	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00454	Repaglinide Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00434	Paclitaxel Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00453	Nateglinide Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00460	Glibenclamide Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00636	Venlafaxine Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00643	Pancreas Function	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00435	Docetaxel Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00625	Imipramine Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00027	Pantothenate and CoA Biosynthesis	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00461	Gliclazide Pathway	1.00000000000207	2.06913026375546e-12	6	0	0	49	995
SMP00605	Ifosfamide Pathway	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00127	Glucose-Alanine Cycle	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00028	Caffeine Metabolism	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00073	Butyrate Metabolism	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00009	Ammonia Recycling	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00448	Ifosfamide Pathway	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00644	Celecoxib Pathway	1.00000000000229	2.28772411021464e-12	8	0	0	49	995
SMP00566	17-alpha-hydroxylase deficiency (CYP17)	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00371	Congenital Lipoid Adrenal Hyperplasia (CLAH) or Lipoid CAH	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00575	11-beta-hydroxylase deficiency (CYP11B1)	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00351	GABA-Transaminase Deficiency	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00610	Clopidogrel Pathway	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00372	Adrenal Hyperplasia Type 5 or Congenital Adrenal Hyperplasia due to 17 Alpha-hydroxylase Deficiency	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00499	Beta-mercaptolactate-cysteine disulfiduria	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00576	21-hydroxylase deficiency (CYP21)	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00577	Corticosterone methyl oxidase I deficiency (CMO I)	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00013	Cysteine Metabolism	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00260	Clopidogrel Pathway	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00578	Corticosterone methyl oxidase II deficiency - CMO II	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00492	Ureidopropionase deficiency	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00628	Nicotine Pathway	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00493	Carnosinuria- carnosinemia	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00466	Transfer of Acetyl Groups into Mitochondria	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00007	Beta-Alanine Metabolism	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00373	Adrenal Hyperplasia Type 3 or Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00130	Steroidogenesis	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00642	Nevirapine Pathway	1.00000000000309	3.08638602633233e-12	9	0	0	49	995
SMP00228	Pantoprazole Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00232	Cimetidine Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00225	Esomeprazole Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00604	Cyclophosphamide Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00230	Ranitidine Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00370	Tyrosinemia Type 3 (TYRO3)	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00008	Phenylalanine and Tyrosine Metabolism	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00226	Omeprazole Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00206	Phenylketonuria	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00589	Gastric Acid Production	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00229	Rabeprazole Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00233	Nizatidine Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00458	Lactose Intolerance	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00227	Lansoprazole Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00231	Famotidine Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00246	Pirenzepine Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00457	Lactose Degradation	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00369	Tyrosinemia Type 2 (or Richner-Hanhart syndrome)	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00447	Cyclophosphamide Pathway	1.00000000000416	4.16409657192272e-12	11	0	0	49	995
SMP00436	Vinblastine Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00580	GLUT-1 deficiency syndrome	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00444	Lactose Synthesis	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00015	Glutathione Metabolism	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00500	5-oxoprolinase deficiency	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00482	Mitochondrial Beta-Oxidation of Long Chain Saturated Fatty Acids	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00516	Adrenoleukodystrophy- X-linked	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00439	Vinorelbine Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00052	Beta Oxidation of Very Long Chain Fatty Acids	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00337	Glutathione Synthetase Deficiency	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00143	5-Oxoprolinuria	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00501	Gamma-glutamyl-transpeptidase deficiency	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00437	Vincristine Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00606	Tamoxifen Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00438	Vindesine Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00517	Carnitine-acylcarnitine translocase deficiency	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00471	Tamoxifen Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00624	Methadone Pathway	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00183	Gamma-Glutamyltransferase Deficiency	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00579	Congenital disorder of glycosylation CDG-IId	1.00000000000418	4.18491899037236e-12	10	0	0	49	995
SMP00543	Homocystinuria due to defect of N(5-10)-methylene THF deficiency	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00030	Oxidation of Branched Chain Fatty Acids	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00432	Methotrexate Pathway	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00053	Folate Metabolism	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00068	Androgen and Estrogen Metabolism	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00467	Trehalose Degradation	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00565	Aromatase deficiency	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00356	17-Beta Hydroxysteroid Dehydrogenase III Deficiency	1.00000000000429	4.291390015796e-12	12	0	0	49	995
SMP00037	Lysine Degradation	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00002	Carbamoyl Phosphate Synthetase Deficiency	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00186	Glutaric Aciduria Type III	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00003	Argininosuccinic Aciduria	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00528	Hyperlysinemia II or Saccharopinuria	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00527	Hyperlysinemia I- Familial	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00603	Gemcitabine Pathway	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00205	Ornithine Transcarbamylase Deficiency (OTC Deficiency)	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00239	Saccharopinuria/Hyperlysinemia II	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00446	Gemcitabine Pathway	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00357	Argininemia	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00571	Pyridoxine dependency with seizures	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00001	Citrullinemia Type I	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00059	Urea Cycle	1.00000000000488	4.88489770263932e-12	13	0	0	49	995
SMP00518	Glucose-6-phosphate dehydrogenase deficiency	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00609	Mercaptopurine Pathway	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00031	Pentose Phosphate Pathway	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00044	Histidine Metabolism	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00191	Histidinemia	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00519	Ribose-5-phosphate isomerase deficiency	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00520	Transaldolase deficiency	1.00000000000588	5.87996718902928e-12	15	0	0	49	995
SMP00622	Morphine Pathway	1.0000000000059	5.89553857225528e-12	16	0	0	49	995
SMP00648	Sorafenib Pathway	1.0000000000059	5.89553857225528e-12	16	0	0	49	995
SMP00048	Nicotinate and Nicotinamide Metabolism	1.00000000000611	6.10942392463841e-12	14	0	0	49	995
SMP00067	Aspartate Metabolism	1.00000000000611	6.10942392463841e-12	14	0	0	49	995
SMP00175	Canavan Disease	1.00000000000611	6.10942392463841e-12	14	0	0	49	995
SMP00192	Hypoacetylaspartia	1.00000000000611	6.10942392463841e-12	14	0	0	49	995
SMP00317	Familial Hypercholanemia (FHCA)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00316	Zellweger Syndrome	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00363	Ornithine Aminotransferase Deficiency (OAT Deficiency)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00442	Etoposide Pathway	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00652	Mycophenolic Acid Pathway	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00315	Cerebrotendinous Xanthomatosis (CTX)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00314	Congenital Bile Acid Synthesis Defect Type II	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00506	Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00035	Bile Acid Biosynthesis	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00507	L-arginine:glycine amidinotransferase deficiency	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00505	Hyperornithinemia with gyrate atrophy (HOGA)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00362	Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00504	Creatine deficiency- guanidinoacetate methyltransferase deficiency	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00207	Prolidase Deficiency (PD)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00360	Hyperprolinemia Type II	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00188	Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00601	Etoposide Pathway	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00208	Prolinemia Type II	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00318	Congenital Bile Acid Synthesis Defect Type III	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00361	Hyperprolinemia Type I	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00020	Arginine and Proline Metabolism	1.00000000000682	6.81592658221192e-12	17	0	0	49	995
SMP00060	Pyruvate Metabolism	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00275	Ardeparin Pathway	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00334	Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00273	Fondaparinux Pathway	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00274	Heparin Pathway	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00196	Leigh Syndrome	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00272	Enoxaparin Pathway	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00212	Pyruvate Dehydrogenase Complex Deficiency	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00558	Primary hyperoxaluria II- PH2	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00559	Pyruvate kinase deficiency	1.00000000000915	9.15403013176474e-12	21	0	0	49	995
SMP00590	Ibuprofen Pathway	1.00000000000927	9.26695682494849e-12	22	0	0	49	995
SMP00282	Streptokinase Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00276	Argatroban Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00288	Aprotinin Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00548	Mitochondrial complex II deficiency	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00279	Ximelagatran Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00281	Anistreplase Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00057	Citric Acid Cycle	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00283	Tenecteplase Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00269	Acenocoumarol Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00280	Alteplase Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00277	Bivalirudin Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00271	Phenprocoumon Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00285	Reteplase Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00551	Pyruvate dehydrogenase deficiency (E2)	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00278	Lepirudin Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00586	Coagulation 	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00284	Urokinase Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00287	Tranexamic Acid Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00546	Congenital lactic acidosis	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00270	Dicumarol Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00286	Aminocaproic Acid Pathway	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00549	2-ketoglutarate dehydrogenase complex deficiency	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00547	Fumarase deficiency	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00550	Pyruvate dehydrogenase deficiency (E3)	1.00000000000932	9.31892760465742e-12	20	0	0	49	995
SMP00219	UMP Synthase Deiciency (Orotic Aciduria)	1.00000000001064	1.06384856232378e-11	23	0	0	49	995
SMP00202	MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy)	1.00000000001064	1.06384856232378e-11	23	0	0	49	995
SMP00172	Beta Ureidopropionase Deficiency	1.00000000001064	1.06384856232378e-11	23	0	0	49	995
SMP00046	Pyrimidine Metabolism	1.00000000001064	1.06384856232378e-11	23	0	0	49	995
SMP00178	Dihydropyrimidinase Deficiency	1.00000000001064	1.06384856232378e-11	23	0	0	49	995
SMP00004	Glycine and Serine Metabolism	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00218	Tyrosinemia Type I	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00484	Dimethylglycinuria	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00244	Sarcosinemia	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00640	Acetaminophen Pathway	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00498	Dopamine beta-hydroxylase deficiency	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00242	Dimethylglycine Dehydrogenase Deficiency	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00223	Non Ketotic Hyperglycinemia	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00179	Dihydropyrimidine Dehydrogenase Deficiency (DHPD)	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00533	Monoamine oxidase-a deficiency (MAO-A)	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00190	Hawkinsinuria	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00006	Tyrosine Metabolism	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00169	Alkaptonuria	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00485	Hyperglycinemia- non-ketotic	1.00000000001159	1.15933553589685e-11	25	0	0	49	995
SMP00078	Chlorothiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00088	Bumetanide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00115	Furosemide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00197	Lysinuric Protein Intolerance	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00105	Metolazone Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00245	Glucose Transporter Defect (SGLT2)	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00090	Bendroflumethiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00100	Hydrochlorothiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00583	Blue diaper syndrome	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00135	Eplerenone Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00483	Kidney Function	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00081	Methyclothiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00108	Hydroflumethiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00134	Spironolactone Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00118	Torsemide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00189	Hartnup Disorder	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00584	Iminoglycinuria	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00133	Amiloride Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00184	Renal Glucosuria	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00097	Ethacrynic Acid pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00091	Quinethazone Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00585	Lysinuric protein intolerance (LPI)	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00132	Triamterene Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00103	Cyclothiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00110	Indapamide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00193	Iminoglycinuria	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00121	Trichlormethiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00080	Polythiazide Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00122	Chlorthalidone Pathway	1.0000000000153	1.52952274021757e-11	32	0	0	49	995
SMP00203	Molybdenium Cofactor Deficiency	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00167	Adenylosuccinate Lyase Deficiency	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00365	Gout or Kelley-Seegmiller Syndrome	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00220	Xanthine Dehydrogenase Deficiency (Xanthinuria)	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00537	Myoadenylate deaminase deficiency	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00050	Purine Metabolism	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00144	Adenosine Deaminase Deficiency	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00536	Mitochondrial DNA depletion syndrome	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00535	Adenine phosphoribosyltransferase deficiency (APRT)	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00512	Xanthinuria type I	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00513	Xanthinuria type II	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00210	Purine Nucleoside Phosphorylase Deficiency	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00364	Lesch-Nyhan Syndrome (LNS)	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00168	AICA-Ribosiduria	1.00000000001716	1.71584594570524e-11	36	0	0	49	995
SMP00428	Mercaptopurine Pathway	1.00000000002159	2.15887198997669e-11	46	0	0	49	995
SMP00430	Thioguanine Pathway	1.00000000002159	2.15887198997669e-11	46	0	0	49	995
SMP00427	Azathioprine Pathway	1.00000000002275	2.27526315218459e-11	49	0	0	49	995
